SUPN
CNS Leader Emerges: Supernus Pharmaceuticals and Indivior Pharmaceuticals Merge to Form Biotech Powerhouse
Supernus Pharmaceuticals and Indivior Pharmaceuticals have made history by merging to form a leading diversified CNS biopharmaceutical company, with significant scale and financial resources. This strategic move is expected to accelerate growth opportunities, drive profitability, and deliver greater value to patients, healthcare communities, and shareholders. In their joint conference call